Affiliation:
1. From the Division of Behavioral Medicine; Department of Biostatistics; and the Division of Stem Cell Transplant, Department of Oncology, St Jude Children's Research Hospital, Memphis, TN
Abstract
PurposeTo describe cognitive and academic outcomes in survivors after pediatric stem-cell transplantation (SCT) through 5-years post-SCT.Patients and MethodsA battery of neurocognitive measures were administered before admission and at 1, 3, and 5 years post-SCT for 268 patients who underwent SCT; the study sample is comprised of 158 patients who survived and were evaluated at 1-year post-SCT. Random coefficient models were generated to depict change over time, and to test differences in slope and intercept for medical and demographic predictor variables.ResultsIn the cohort as a whole, no significant changes were seen in global intelligence quotient and academic achievement. Despite the overall stability, some significant differences in slopes were found based on diagnosis, type of transplantation, use of total-body irradiation (TBI), and presence of graft-versus-host disease (GVHD). However, these differences were small, and of limited clinical significance. In comparison, differences as a function of socioeconomic status (SES) were much larger. SES was a significant determinant of all cognitive and academic outcomes, and the effect size generally dwarfed that of other significant predictor variables. Age, which had previously been identified as an important determinant of outcome, was not significantly predictive of outcome in this cohort.ConclusionThe procedure of SCT entails minimal risk of late cognitive and academic sequelae. Subgroups of patients are at relatively higher risk: patients undergoing unrelated donor transplantation, receiving TBI, and those who experience GVHD. However, these differences are small relative to differences in premorbid functioning, particularly those associated with SES.
Publisher
American Society of Clinical Oncology (ASCO)
Reference44 articles.
1. Santos GW: Historical background to hematopoietic stem cell transplantation, in Atkinson K (ed): Clinical Bone Marrow and Blood Stem Cell Transplantation (ed 2). New York, NY, Cambridge University Press, pp 1,2000-12
2. Bollard CM, Krance RA, Heslop HE: Hematopoietic stem cell transplantation in pediatric oncology, in Pizzo PA, Poplack DG (eds): Principles and Practices of Pediatric Oncology (ed 5). Philadelphia, PA, Lippincott Williams & Wilkins, pp 476,2006-500
3. Toxicities of total-body irradiation for pediatric bone marrow transplantation
4. Efficacy and toxicity of radiation in preparative regimens for pediatric stem cell transplantation. I: Clinical applications and therapeutic effects
5. Coley SC, Porter DA, Calamante F, et al: Quantitative MR diffusion mapping and cyclosporine-induced neurotoxicity. Amer J Neuroradiology 20:1507,1999-1510,
Cited by
72 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献